Literature DB >> 21586611

MicroRNA sequence and expression analysis in breast tumors by deep sequencing.

Thalia A Farazi1, Hugo M Horlings, Jelle J Ten Hoeve, Aleksandra Mihailovic, Hans Halfwerk, Pavel Morozov, Miguel Brown, Markus Hafner, Fabien Reyal, Marieke van Kouwenhove, Bas Kreike, Daoud Sie, Volker Hovestadt, Lodewyk F A Wessels, Marc J van de Vijver, Thomas Tuschl.   

Abstract

MicroRNAs (miRNA) regulate many genes critical for tumorigenesis. We profiled miRNAs from 11 normal breast tissues, 17 noninvasive, 151 invasive breast carcinomas, and 6 cell lines by in-house-developed barcoded Solexa sequencing. miRNAs were organized in genomic clusters representing promoter-controlled miRNA expression and sequence families representing seed sequence-dependent miRNA target regulation. Unsupervised clustering of samples by miRNA sequence families best reflected the clustering based on mRNA expression available for this sample set. Clustering and comparative analysis of miRNA read frequencies showed that normal breast samples were separated from most noninvasive ductal carcinoma in situ and invasive carcinomas by increased miR-21 (the most abundant miRNA in carcinomas) and multiple decreased miRNA families (including miR-98/let-7), with most miRNA changes apparent already in the noninvasive carcinomas. In addition, patients that went on to develop metastasis showed increased expression of mir-423, and triple-negative breast carcinomas were most distinct from other tumor subtypes due to upregulation of the mir~17-92 cluster. However, absolute miRNA levels between normal breast and carcinomas did not reveal any significant differences. We also discovered two polymorphic nucleotide variations among the more abundant miRNAs miR-181a (T19G) and miR-185 (T16G), but we did not identify nucleotide variations expected for classical tumor suppressor function associated with miRNAs. The differentiation of tumor subtypes and prediction of metastasis based on miRNA levels is statistically possible but is not driven by deregulation of abundant miRNAs, implicating far fewer miRNAs in tumorigenic processes than previously suggested. ©2011 AACR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21586611      PMCID: PMC3129492          DOI: 10.1158/0008-5472.CAN-11-0608

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  46 in total

Review 1.  The widespread regulation of microRNA biogenesis, function and decay.

Authors:  Jacek Krol; Inga Loedige; Witold Filipowicz
Journal:  Nat Rev Genet       Date:  2010-07-27       Impact factor: 53.242

2.  Molecular portraits of human breast tumours.

Authors:  C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

3.  MicroRNA gene expression deregulation in human breast cancer.

Authors:  Marilena V Iorio; Manuela Ferracin; Chang-Gong Liu; Angelo Veronese; Riccardo Spizzo; Silvia Sabbioni; Eros Magri; Massimo Pedriali; Muller Fabbri; Manuela Campiglio; Sylvie Ménard; Juan P Palazzo; Anne Rosenberg; Piero Musiani; Stefano Volinia; Italo Nenci; George A Calin; Patrizia Querzoli; Massimo Negrini; Carlo M Croce
Journal:  Cancer Res       Date:  2005-08-15       Impact factor: 12.701

4.  Monoallelic but not biallelic loss of Dicer1 promotes tumorigenesis in vivo.

Authors:  I Lambertz; D Nittner; P Mestdagh; G Denecker; J Vandesompele; M A Dyer; J-C Marine
Journal:  Cell Death Differ       Date:  2009-12-18       Impact factor: 15.828

5.  Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases.

Authors:  Irene Catucci; Rongxi Yang; Paolo Verderio; Sara Pizzamiglio; Ludwig Heesen; Kari Hemminki; Christian Sutter; Barbara Wappenschmidt; Michelle Dick; Norbert Arnold; Peter Bugert; Dieter Niederacher; Alfons Meindl; Rita K Schmutzler; Claus C Bartram; Filomena Ficarazzi; Laura Tizzoni; Daniela Zaffaroni; Siranoush Manoukian; Monica Barile; Marco A Pierotti; Paolo Radice; Barbara Burwinkel; Paolo Peterlongo
Journal:  Hum Mutat       Date:  2010-01       Impact factor: 4.878

6.  Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.

Authors:  Junichi Takamizawa; Hiroyuki Konishi; Kiyoshi Yanagisawa; Shuta Tomida; Hirotaka Osada; Hideki Endoh; Tomoko Harano; Yasushi Yatabe; Masato Nagino; Yuji Nimura; Tetsuya Mitsudomi; Takashi Takahashi
Journal:  Cancer Res       Date:  2004-06-01       Impact factor: 12.701

7.  Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies.

Authors:  Michael D Mattie; Christopher C Benz; Jessica Bowers; Kelly Sensinger; Linda Wong; Gary K Scott; Vita Fedele; David Ginzinger; Robert Getts; Chris Haqq
Journal:  Mol Cancer       Date:  2006-06-19       Impact factor: 27.401

8.  RNA editing of human microRNAs.

Authors:  Matthew J Blow; Russell J Grocock; Stijn van Dongen; Anton J Enright; Ed Dicks; P Andrew Futreal; Richard Wooster; Michael R Stratton
Journal:  Genome Biol       Date:  2006-04-04       Impact factor: 13.583

9.  A microRNA expression signature of human solid tumors defines cancer gene targets.

Authors:  Stefano Volinia; George A Calin; Chang-Gong Liu; Stefan Ambs; Amelia Cimmino; Fabio Petrocca; Rosa Visone; Marilena Iorio; Claudia Roldo; Manuela Ferracin; Robyn L Prueitt; Nozumu Yanaihara; Giovanni Lanza; Aldo Scarpa; Andrea Vecchione; Massimo Negrini; Curtis C Harris; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-03       Impact factor: 11.205

10.  MicroRNAs and cancer: short RNAs go a long way.

Authors:  Andrea Ventura; Tyler Jacks
Journal:  Cell       Date:  2009-02-20       Impact factor: 41.582

View more
  179 in total

1.  Differential expression of microRNA expression in tamoxifen-sensitive MCF-7 versus tamoxifen-resistant LY2 human breast cancer cells.

Authors:  Tissa T Manavalan; Yun Teng; Savitri N Appana; Susmita Datta; Theodore S Kalbfleisch; Yong Li; Carolyn M Klinge
Journal:  Cancer Lett       Date:  2011-09-10       Impact factor: 8.679

2.  Breast Cancer-Specific miR Signature Unique to Extracellular Vesicles Includes "microRNA-like" tRNA Fragments.

Authors:  Nicole Guzman; Kitty Agarwal; Dilip Asthagiri; Lianbo Yu; Motoyasu Saji; Matthew D Ringel; Michael E Paulaitis
Journal:  Mol Cancer Res       Date:  2015-02-26       Impact factor: 5.852

3.  Genetic analysis and preliminary function study of miR-423 in breast cancer.

Authors:  Huanhuan Zhao; Ang Gao; Zhiqian Zhang; Ruoyu Tian; Ang Luo; Mei Li; Dan Zhao; Liya Fu; Li Fu; Jin-Tang Dong; Zhengmao Zhu
Journal:  Tumour Biol       Date:  2015-02-08

4.  The MicroRNA miR-210 Is Expressed by Cancer Cells but Also by the Tumor Microenvironment in Triple-Negative Breast Cancer.

Authors:  Isabelle Bar; Ahmad Merhi; Fadi Abdel-Sater; Abduelhakem Ben Addi; Sara Sollennita; Jean-Luc Canon; Paul Delrée
Journal:  J Histochem Cytochem       Date:  2017-04-12       Impact factor: 2.479

5.  Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA.

Authors:  Stefano Volinia; Marco Galasso; Maria Elena Sana; Timothy F Wise; Jeff Palatini; Kay Huebner; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-06       Impact factor: 11.205

6.  Identification of miR-423 and miR-499 polymorphisms on affecting the risk of hepatocellular carcinoma in a large-scale population.

Authors:  Yanyun Ma; Rui Wang; Jun Zhang; Wenshuai Li; Chunfang Gao; Jie Liu; Jiucun Wang
Journal:  Genet Test Mol Biomarkers       Date:  2014-05-22

7.  Identification of conserved and novel microRNAs in cerebral ischemia-reperfusion injury of rat using deep sequencing.

Authors:  Chunmei Wang; Yanyou Pan; Baohua Cheng; Jing Chen; Bo Bai
Journal:  J Mol Neurosci       Date:  2014-07-26       Impact factor: 3.444

8.  Modulation of LIN28B/Let-7 Signaling by Propranolol Contributes to Infantile Hemangioma Involution.

Authors:  Ezinne Francess Mong; Kemal Marc Akat; John Canfield; John Lockhart; Jeffrey VanWye; Andrew Matar; John C M Tsibris; June K Wu; Thomas Tuschl; Hana Totary-Jain
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-05-03       Impact factor: 8.311

Review 9.  Functional Role of miRNAs in the Progression of Breast Ductal Carcinoma in Situ.

Authors:  Bethany N Hannafon; Wei-Qun Ding
Journal:  Am J Pathol       Date:  2018-09-29       Impact factor: 4.307

10.  A MicroRNA196a2* and TP63 circuit regulated by estrogen receptor-α and ERK2 that controls breast cancer proliferation and invasiveness properties.

Authors:  Kyuri Kim; Zeynep Madak-Erdogan; Rosa Ventrella; Benita S Katzenellenbogen
Journal:  Horm Cancer       Date:  2012-12-19       Impact factor: 3.869

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.